- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT04876274
Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic
Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic: a Randomized Controlled Trial in Taiwan
The current study was to develop a software "Line@" based health education program, providing video-based health information and communication between diabetes patients and health-care professionals. This study also evaluated its effectiveness on improving glycemic control, attitude towards diabetes, knowledge about diabetes and self-care for type 2 diabetes patients in Taiwan.
The followings were the hypotheses of the study:
- Compared to the control group, intervention group receiving "Line" based video education has a greater improvement on glycosylated hemoglobin (A1C).
- Compared to the control group, intervention group receiving "Line" based video education has a greater positive effect on attitude towards diabetes.
- Compared to the control group, intervention group receiving "Line" based video education has a better understanding on diabetic knowledge.
- Compared to the control group, intervention group receiving "Line" based video education has a greater positive effect on self-care activity.
Descripción general del estudio
Descripción detallada
The study was conducted in the Endocrinology and Metabolism Clinic in Taipei Medical University Wang-Fang Hospital. Patients were referred from physicians if they met the inclusion criteria and consent to join. Written consent and questionnaires were then provided to the participants after researcher had clearly explained the study purpose.
Based on the seven key points in managing diabetes developed by the association of diabetes care and education specialist (ADCES), including healthy coping, healthy eating, being active, monitoring, taking medication, problem solving and reducing risks, the research team had developed 51 diabetes related health educational videos (available at website of School of Pharmacy, Taipei Medical University http://pharmschool.tmu.edu.tw/activity/index.php?type=20). Each video lasted for about 2-3 minutes. According to the content of the videos, it was categorized into 5 domains, including understanding diabetes, daily care, nutrition care, diabetes drug and diabetes knowledge related quizzes.
Patients in intervention group could attend the video through the line platform. Researcher would also send 2-3 videos per week with care massage every 2 weeks to the patients. The general schedule of video was shown in table x. According to various condition, researcher developed specific video schedule for each patients. For example, patient who was prescribed with A drug, we would only send the video regarding A drug to this patient but not all of the video regarding drugs. Schedule for the part of understanding diabetes, daily care, nutrition care and quizzes was the same among all participants. Due to the quizzes that were put in week 3, 6, 9 and 12, videos related to general knowledge about diabetes would be send to patients first to make sure all the quizzes related content had already taught to patients before the quizzes. Moreover, patients could communicate with the research team and ask questions through the platform, researcher would provide answers verified by pharmacists or physicians in one or two days after.
The sample size of this study was estimated using G-power (version 3.1). Assuming a power of 80% with two-sided alpha level for detecting the difference between the intervention group and the control group, at least 64 patients were needed for each group. Considering 20% dropout rate, the study was designed to have at least 80 patients for each group, 160 patients in total.
Patients were randomized in a 1:1 ratio according to the random allocation sequence generated prior to the study. Patients with odd number were allocated into control group while even numbers were allocated into intervention group. The trial was non-blinded because of its feasibility.
Researcher would not provide any inductive explanation to the patient during filling the questionnaire. If patient had questions about the items, a detailed explanation and health education were provided only after finishing the post-test. The returned questionnaires were collected by the researcher and kept in the Department of Clinical Pharmacy, School of Pharmacy, Taipei Medical University for three years.
All the data were analyzed using SPSS (SPSS Inc. Released 2009. Predictive Analytics Suite Workstation (PASW) Statistics for Windows, Version 18.0. Chicago: SPSS Inc.). A two-tailed p value of 0.05 was considered to be statistically significant in the analysis. For personal characteristics, descriptive analysis was performed. According to the characteristic of data, Chi-square test and t-test was used for detecting the differences between groups. a Wilcoxon signed rank test or paired t-tests was performed for the differences in A1C and the scores between pre and post-test about knowledge, self-care activity and attitude towards diabetes. A Mann-Whitney test or unpaired t-tests was performed for the mean differences between control and intervention group. Logistics regression was performed for the correlation between variables.
Patients who had finished both pre- and post-assessment would be included for analysis, those without post-test would be excluded. Missing values were processed by multiple imputation.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Taipei, Taiwán
- School of Pharmacy, Taipei Medical University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Type 2 Diabetes mellitus (T2DM)
- Age 20 or older
- Had at least 1 A1C data in the past 6 months
- Possessed a smart-cellphone
- A1C ≥ 6%
Exclusion Criteria:
- Gestational diabetes
- Cognitive impairment
- No medication treatment but dietary control alone
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Intervention group
Patients in the intervention group received Taipei Medical University (TMU) line-oriented video education and care in addition to usual care
|
Patients in intervention group could attend diabetes-related health educational video through the TMU-LOVE platform.
Researcher would also send 2-3 videos per week with care massage every 2 weeks to the patients.
|
|
Sin intervención: Control group
Patients in the control group received usual care
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
HbA1C
Periodo de tiempo: 12 weeks
|
Improvement in glycemic control
|
12 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Score of Diabetes Care Profile-Attitudes Toward Diabetes Scales
Periodo de tiempo: 12 weeks
|
The Chinese version of Diabetes Care Profile-Attitudes Toward Diabetes Scales (DCP-ATDS) was used for measuring patients' attitude towards diabetes at baseline and 12 weeks.
Each item was rated on a five-point Likert scale, the total score was in the range of 23-115, in which higher scores mean patient had better attitudes towards diabetes.
|
12 weeks
|
|
Score of Summary of Diabetes Self-Care Activities
Periodo de tiempo: 12 weeks
|
The Chinese version of Summary of Diabetes Self-Care Activities (SDSCA) was used for measuring patients' self-care activities at baseline and 12 weeks.
Each item was rated from 0 to 7. For patients who were prescribed with either oral medication or insulin injection, the total score ranged from 0 to 63.
The total score for patients who were taking both oral and insulin medications ranged from 0 to 70.
The mean scores were calculated separately according to the total score ranges.
A higher scores mean better self-care behavior.
|
12 weeks
|
|
Score of Simplified True / False Version of Diabetes Knowledge Scale
Periodo de tiempo: 12 weeks
|
The Chinese version of Simplified true/false version of revised Diabetes Knowledge Scale (SDKS) was used for measuring patients' knowledge about diabetes at baseline and 12 weeks.
A score of "1" was given if the patient responded with the correct answer and "0" was given for incorrect answer or answered with "Don't know".
For patients who were prescribed with insulin treatment, the total score ranged from 0 to 24, for those without insulin treatment, the total score ranged from 0 to 22.
The mean scores were calculated separately according to the total score ranges.
A higher score indicated higher level of knowledge about diabetes.
|
12 weeks
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Score of Newest Vital Sign
Periodo de tiempo: 12 weeks
|
The Chinese version of Newest Vital Sign (NVS) was used for measuring patients' health literacy level.
A score of "1" was given if the patient responded with the correct answer and "0" was given for incorrect answer.
The total score ranged from 0 to 6, with higher scores mean better health literacy level.
|
12 weeks
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Director de estudio: Chen Hsiang-Yin, Pharm.D., Professor and Associate Dean, College of Pharmacy, Taipei Medical University
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Trastornos del metabolismo de la glucosa
- Enfermedades metabólicas
- Infecciones por coronavirus
- Infecciones por coronaviridae
- Infecciones por Nidovirales
- Infecciones por virus de ARN
- Enfermedades virales
- Infecciones
- Infecciones del Tracto Respiratorio
- Enfermedades de las vías respiratorias
- Neumonía Viral
- Neumonía
- Enfermedades pulmonares
- Enfermedades del sistema endocrino
- Diabetes mellitus
- COVID-19
- Diabetes Mellitus, Tipo 2
Otros números de identificación del estudio
- TMU-LOVE
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Diabetes tipo 2
-
Jin-Hee AhnAsan Medical CenterDesconocidoAmplificación del gen HER-2 | Sobreexpresión de proteína HER-2
-
Instituto Nacional de Ciencias Medicas y Nutricion...Activo, no reclutando
-
The University of Tennessee, KnoxvilleTerminadoProfesores de Matemáticas (Grados 2-8) | Estudiantes de Matemáticas (Grados 2-8)Estados Unidos
-
Embecta Corp.Jaeb Center for Health ResearchRetiradoDiabetes tipo 2 | Diabetes mellitus tipo 2 (DM2) | DM2 (Diabetes Mellitus Tipo 2) | DT2 | DMT2 | DM tipo 2 | DM2 con control glucémico inadecuadoEstados Unidos
-
Kaiser PermanenteThe Permanente Medical GroupInscripción por invitaciónDiabetes tipo 2 | Diabetes mellitus tipo 2 (DM2) | Diabetes tipo 2 (DT2)Estados Unidos
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... y otros colaboradoresReclutamientoDiabetes tipo 2 | Diabetes mellitus tipo 2Turquía (Türkiye)
-
PowderMedTerminado
-
University of MiamiSexual Medicine Society of North America Inc.Aún no reclutandoDiabetes tipo 2 | Diabetes tipo 2 (DM2)Estados Unidos
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.DesconocidoTumor solido | Amplificación del gen HER-2 | Mutación del gen HER2 | Sobreexpresión de proteína HER-2Porcelana
-
Endogenex, Inc.Aún no reclutandoDiabetes Mellitus, Tipo 2 | Diabetes | Diabetes mellitus tipo 2 | Diabetes tipo 2 | Diabetes tipo 2
Ensayos clínicos sobre TMU-LOVE
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA)TerminadoInfecciones por VIHEstados Unidos
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteTerminadoInfecciones por VIHEstados Unidos
-
Love WellnessCitruslabsTerminadoSalud vaginal | PH vaginalEstados Unidos
-
Sha Research FoundationAún no reclutandoCalidad de vida | ADN mitocondrialCanadá
-
Hartford HospitalUniversity of Maryland; University of ConnecticutTerminadoRespuesta inflamatoria | Prolapso de órganos pélvicos | DisbiosisEstados Unidos
-
Peking University First HospitalTerminadoLipomatosis pélvica | Cistitis GlandularPorcelana